Struma zwelling schildklier
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients with symptomatic goitre - Goitre size larger than 40 ml on one side determined on CT - Patients accept both treatment modalities - TSH between 0,5-5,0 mE/L (euthyroidism) without Thyroid suppletion - Not pregnant or childwish within 64 months after treatment - Able to undergo surgery as well as radioiodine treatment (hoe te definieren) - Able to fill in questionnaires and give Informed Consent - 18 years or older
Exclusion criteria
Exclusion criteria: - Goitre suspicious of malignancy on imaging - Bethesda 5 or 6 cytology - Hyperthyroidism - Previous history of thyroid surgery or radioactive iodine - Not eligible for general anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the reduction of symptoms 12 months after treatment, as measured by a decrease of complaints on self-reported QoL questionnaire (THYRPRO). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are goiter volume as measured on a CT-scan without contrast 1 year after treatment and complications (vocal cords palsy, hypo- or hyperthyroidism. | — |
Countries
Netherlands